Astera Labs President/COO discloses 280k share sales under Rule 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Gajendra Sanjay, President and COO of Astera Labs (ALAB), reported automated sales under a Rule 10b5-1 plan adopted November 30, 2024. On 08/07/2025 he sold a total of 280,000 shares in multiple transactions at prices ranging approximately from $165.17 to $175.00. Following the sales, the filing shows Trust 1 holds 5,525,545 shares, Trust 2 and Trust 3 each hold 695,000 shares, and the reporting person directly holds 2,262,318 shares. The filing disclaims beneficial ownership of the trust-held shares except for any pecuniary interest, and the reporting person offers to provide transaction-level price details on request.
Positive
- Sales executed under a Rule 10b5-1 plan, indicating pre-arranged transactions that reduce appearance of opportunistic insider trading
- Transparent disclosure including weighted-average price ranges and an offer to provide per-trade details on request
Negative
- Substantial insider sales totaling 280,000 shares on 08/07/2025 by the company's President and COO
- Trust-held shares are disclaimed by the reporting person, which may obscure direct beneficial ownership clarity
Insights
TL;DR: Officer sales under a pre-planned 10b5-1 program reduce timing concerns but highlight significant insider liquidity.
The report documents 280,000 shares sold under a Rule 10b5-1 plan, showing pre-arranged disposition rather than opportunistic timing. The filing transparently provides weighted-average price ranges and an offer to disclose per-trade details, which is good governance practice. However, large scheduled sales by a senior officer warrant investor attention to potential dilution or insider liquidity patterns, even though trust-held shares are disclaimed for beneficial ownership.
TL;DR: The sales are sizable in absolute terms but their material impact is unclear without outstanding share counts; reporting is thorough.
The disclosure lists sequential sales at weighted-average prices between about $165.17 and $175.00, and final Trust 1 holdings of 5,525,545 shares plus two trusts at 695,000 each and 2,262,318 held directly. Because the filing notes the 10b5-1 plan adoption date, these transactions appear routine under a pre-existing plan; investors should note the magnitude of insider selling relative to the issuer's float when assessing impact.
Insider Trade Summary
Net Seller: 280,000 shares ($47,604,991)
Net Sell
13 txns
Insider
Gajendra Sanjay
Role
President and COO
Sold
280,000 shs ($47.60M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,375 | $165.7531 | $891K |
| Sale | Common Stock | 17,587 | $166.8344 | $2.93M |
| Sale | Common Stock | 28,478 | $167.5665 | $4.77M |
| Sale | Common Stock | 42,149 | $168.7086 | $7.11M |
| Sale | Common Stock | 32,363 | $169.6732 | $5.49M |
| Sale | Common Stock | 79,591 | $170.6655 | $13.58M |
| Sale | Common Stock | 43,127 | $171.6537 | $7.40M |
| Sale | Common Stock | 22,430 | $172.5331 | $3.87M |
| Sale | Common Stock | 5,900 | $173.7347 | $1.03M |
| Sale | Common Stock | 3,000 | $174.8869 | $525K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 5,800,170 shares (Indirect, By Trust 1);
Common Stock — 2,262,318 shares (Direct)
Footnotes (1)
- The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.1700 to $166.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $166.1700 to $167.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.1700 to $168.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.1700 to $169.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.1700 to $170.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.1700 to $171.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.1700 to $172.1600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $172.1700 to $173.1300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.1700 to $174.1550, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $174.2900 to $175.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
FAQ
What transactions did the Form 4 for Astera Labs (ALAB) report?
The Form 4 reports that Gajendra Sanjay sold 280,000 shares on 08/07/2025 under a Rule 10b5-1 trading plan.
Were these sales discretionary or part of a plan for ALAB insider?
The sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2024.